Suppr超能文献

抗艾滋病药物 79. 新型二金刚烷酰-2',2'-二甲基二氢吡喃并色酮 (DCP) 类似物作为有效抗 HIV 药物的设计、合成、分子建模和构效关系。

Anti-AIDS agents 79. Design, synthesis, molecular modeling and structure-activity relationships of novel dicamphanoyl-2',2'-dimethyldihydropyranochromone (DCP) analogs as potent anti-HIV agents.

机构信息

Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.

出版信息

Bioorg Med Chem. 2010 Sep 15;18(18):6678-89. doi: 10.1016/j.bmc.2010.07.065. Epub 2010 Aug 2.

Abstract

In a continued study, 23 3'R,4'R-di-O-(-)-camphanoyl-2',2'-dimethyldihydropyrano[2,3-f]chromone (DCP) derivatives (5-27) were synthesized, and screened for anti-HIV activity against both a non-drug-resistant NL4-3 strain and multiple reverse transcriptase (RT) inhibitor-resistant (RTMDR-1) strain, using 2-EDCP (4) and 2-MDCP (35) as controls. New DCP analogs 5, 9, 14, and 22 exhibited potent anti-HIV activity against HIVNL4-3 with EC50 and therapeutic index (TI) values ranging from 0.036 microM to 0.14 microM and from 110 to 420, respectively. Compounds 5 and 9 also exhibited good activity against RTMDR-1 (EC50 0.049 and 0.054 microM; TI 310 and 200, respectively), and were twofold more potent than the leads 4 and 35 (EC50 0.11 and 0.19 microM; TI 60 and 58, respectively). Evaluation of water solubility showed that 5 and 22 were 5-10 times more water soluble than 4. Quantitative structure-activity relationship (QSAR) modeling results were first performed on this compound type, and the models should aid in design of future anti-HIV DCP analogs and potential clinical drug candidates.

摘要

在一项持续的研究中,合成了 23 个 3'R,4'R-二-O-(-)-莰烷酰基-2',2'-二甲基二氢吡喃并[2,3-f]色酮 (DCP) 衍生物(5-27),并对其抗 HIV 活性进行了筛选,针对非耐药 NL4-3 株和多种逆转录酶(RT)抑制剂耐药(RTMDR-1)株,以 2-EDCP(4)和 2-MDCP(35)为对照。新的 DCP 类似物 5、9、14 和 22 对 HIVNL4-3 表现出很强的抗 HIV 活性,EC50 和治疗指数(TI)值分别为 0.036 μM 至 0.14 μM 和 110 至 420。化合物 5 和 9 对 RTMDR-1 也表现出良好的活性(EC50 为 0.049 和 0.054 μM;TI 分别为 310 和 200),比先导化合物 4 和 35 强两倍(EC50 为 0.11 和 0.19 μM;TI 分别为 60 和 58)。水溶性评估表明,5 和 22 的水溶性比 4 高 5-10 倍。首次对该化合物类型进行了定量构效关系(QSAR)建模研究,这些模型应该有助于设计未来的抗 HIV DCP 类似物和潜在的临床候选药物。

相似文献

引用本文的文献

本文引用的文献

2
Global epidemiology of HIV.全球艾滋病病毒流行病学。
Curr Opin HIV AIDS. 2009 Jul;4(4):240-6. doi: 10.1097/COH.0b013e32832c06db.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验